Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and injection volume.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  1997-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 9103484
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacology and clinical uses of testosterone

  1998cited by this paper
• Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility.

  1995cited by this paper
• Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men

  1995cited by this paper
• Physiologic indirect response models characterize diverse types of pharmacodynamic effects

  1994cited by this paper
• Recombinant growth hormone and insulin-like growth factor I do not alter gonadotrophin stimulation of the baboon testis in vivo.

  1994cited by this paper
• Pharmacokinetics of once-a-month injectable contraceptives.

  1994cited by this paper
• Comparison of four basic models of indirect pharmacodynamic responses

  1993cited by this paper
• Comparison of two androgens plus depot-medroxyprogesterone acetate for suppression to azoospermia in indonesian men. World Health Organization. Task Force on Methods for the Regulation of Male Fertility.

  1993cited by this paper
• Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.

  1993cited by this paper
• Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men.

  1992cited by this paper
• Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

  1992cited by this paper
• Circulating immunoreactive inhibin and testosterone levels in men with critical illness

  1992cited by this paper
• Contraceptive efficacy of testosterone‐induced azoospermia in normal men

  1991cited by this paper
• Statistical Models in S

  1991cited by this paper
• Highly vectorial secretion of inhibin by primate Sertoli cells in vitro.

  1990cited by this paper
• Serum inhibin concentrations before and during gonadotropin treatment in men with hypogonadotropic hypogonadism: physiological and clinical implications.

  1990cited by this paper
• Comparative pharmacokinetics of androgen preparations: Application of computer analysis and simulation

  1990cited by this paper
• BMPD statistical software manual

  1988cited by this paper
• Release and absorption rate aspects of intramuscularly injected pharmaceuticals

  1988cited by this paper
• Influence of solvent on the availability of testosterone propionate from oily, intramuscular injections in the rat

  1987cited by this paper
• Pharmacokinetic properties of testosterone propionate in normal men.

  1986cited by this paper
• Pharmacokinetics of 19-nortestosterone esters in normal men.

  1985cited by this paper
• Pharmacokinetic parameters of nandrolone (19-nortestosterone) after intramuscular administration of nandrolone decanoate (Deca-Durabolin) to healthy volunteers.

  1985cited by this paper
• Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate as assessed by serum and salivary testosterone levels in normal men.

  1984cited by this paper
• Sex differences in the absorption of dapsone after intramuscular injection.

  1983cited by this paper
• Intramuscular or intralipomatous injections?

  1982cited by this paper
• Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum after injection of testosterone enanthate of testosterone cypionate.

  1980cited by this paper
• Testosterone radioimmunoassay: rapid extraction technique for steroids based on kieselguhr mini-columns.

  1980cited by this paper
• Intramuscular injection of drugs.

  1976cited by this paper
• Bioavailability and LH-suppressing effect of different testosterone preparations in normal and hypogonadal men.

  1976cited by this paper
• Blood flow in muscle groups and drug absorption

  1975cited by this paper
• Intramuscular absorption of drugs from oily solutions in the rat.

  1974cited by this paper
• Absorption rates of various substances administered intramuscularly.

  1971cited by this paper
• Biopharmaceutical considerations in subcutaneous and intramuscular drug administration.

  1968cited by this paper
• ON THE MECHANISM OF ACTION OF NANDROLONE PHENYLPROPIONATE AND NANDROLONE DECANOATE IN RATS.

  1965cited by this paper
• Androgens

  1964influential reference
• Long-acting steroids in reproduction.

  1957cited by this paper

• Testosterone Therapy: Injectable Androgens

  2025cites this paper
• Nandrolone decanoate–induced hypogonadism in male rats: Dose‐ and time‐dependent effects on pituitary and testicular hormonal functions

  2024influential citation
• Development of a bio-relevant in vitro release testing method for subcutaneous and intramuscular oil depot formulations

  2024cites this paper
• Development and approval of novel injectables: enhancing therapeutic innovations

  2024cites this paper
• Single and multi‐dose pharmacology of recombinant and urinary human chorionic gonadotrophin in men

  2024cites this paper
• Recent advances in lipid-based long-acting injectable depot formulations.

  2023cites this paper
• Mitochondrial dysfunction and cardiac ischemia/reperfusion injury are attenuated by nandrolone: Role of JAK-STAT3 pathway.

  2023cites this paper
• Performance assessment of an equine metabolomics model for screening a range of anabolic agents

  2023cites this paper
• Nandrolone decanoate and testosterone undecanoate differently affect stress hormones, neurotransmitter systems, and general activity in the male rat.

  2022cites this paper
• Impact of ageing on the pharmacokinetics and pharmacodynamics of the drugs

  2022cites this paper
• Anabolic–androgenic steroids: How do they work and what are the risks?

  2022cites this paper
• Lipid based intramuscular long-acting injectables: current state of the art.

  2022cites this paper
• Opportunities and Challenges of Fatty Acid Conjugated Therapeutics.

  2021cites this paper
• Testosterone Therapy with Subcutaneous Injections: A Safe, Practical and Reasonable Option.

  2021cites this paper
• Anabolic steroid excess promotes hydroelectrolytic and autonomic imbalance in adult male rats: Is it enough to alter blood pressure?

  2020cites this paper
• Development and evaluation of intramuscularly administered nano/microcrystal suspension

  2019cites this paper
• Geriatric Pharmacology: An Update.

  2019cites this paper
• Nandrolone decanoate administration does not attenuate muscle atrophy during a short period of disuse

  2019cites this paper
• Voluntary alcohol drinking : relation to corticosteroids and alcohol-mediated testosterone elevation

  2017cites this paper
• The contribution of the in-vivo fate of an oil depot to drug absorption.

  2017influential citation
• Translational studies on a ready-to-use intramuscular injection of penethamate for bovine mastitis

  2017cites this paper
• Pharmacokinetics of testosterone cream applied to scrotal skin

  2017cites this paper
• Insights on Fatty Acids in Lipophilic Prodrug Strategy

  2017cites this paper
• Testosterone Therapy: Injectable Androgens

  2017cites this paper
• Spatial distribution of oil depots monitored in human muscle using MRI.

  2016cites this paper
• Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.

  2016cites this paper
• Where does hydrolysis of nandrolone decanoate occur in the human body after release from an oil depot?

  2016cites this paper
• Pharmacokinetics in Elderly Women of Benzyl Alcohol From an Oil Depot.

  2016cites this paper
• Fundamental understanding of drug absorption from a parenteral oil depot.

  2016cites this paper
• Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestation.

  2016cites this paper
• Lipoic acid and pentoxifylline mitigate nandrolone decanoate-induced neurobehavioral perturbations in rats via re-balance of brain neurotransmitters, up-regulation of Nrf2/HO-1 pathway, and down-regulation of TNFR1 expression.

  2015cites this paper
• Lipid-Based Carriers for Prodrugs to Enhance Delivery

  2015cites this paper
• The beneficial effects of strength exercise on hippocampal cell proliferation and apoptotic signaling is impaired by anabolic androgenic steroids.

  2014cites this paper
• Lipid-Based Drug Carriers for Prodrugs to Enhance Drug Delivery

  2014cites this paper
• Pharmacokinetic-pharmacodynamic study of subcutaneous injection of depot nandrolone decanoate using dried blood spots sampling coupled with ultrapressure liquid chromatography tandem mass spectrometry assays.

  2014cites this paper
• Immunoreactive LH in long-term frozen human urine samples.

  2014cites this paper
• GH improves spatial memory and reverses certain anabolic androgenic steroid-induced effects in intact rats.

  2013cites this paper
• Growth Hormone and Anabolic Androgenic Steroids : Effects on Neurochemistry and Cognition

  2013cites this paper
• Androgen Physiology, Pharmacology and Abuse

  2013cites this paper
• Use of in vitro release models in the design of sustained and localized drug delivery systems for subcutaneous and intra-articular administration

  2013cites this paper
• On the association between nandrolone-mediated testosterone reduction during alcohol intoxication and attenuated voluntary alcohol intake in rats.

  2013cites this paper
• Regulatory Issues and Challenges Associated with the Development of Performance Specifications for Modified Release Parenteral Products

  2012cites this paper
• In Vitro Drug Release Testing and In Vivo/In Vitro Correlation for Long Acting Implants and Injections

  2012cites this paper
• Testosterone: Testosterone preparations for clinical use in males

  2012cites this paper
• A Short History of Controlled Drug Release and an Introduction

  2011cites this paper
• Cardiovascular consequences of anabolic steroid use

  2011cites this paper
• Impact of anabolic androgenic steroids on neuropeptide systems.

  2011cites this paper
• Anabolic Steroids: Metabolism, Doping and Detection in Human and Equestrian Sports

  2010cites this paper
• Conversion of 4-Norandrostenedione, 4-Norandrostenediol and 5- Norandrostenediol to Nandrolone in Human Subjects

  2010cites this paper
• Factors influencing time course of pain after depot oil intramuscular injection of testosterone undecanoate.

  2010cites this paper
• Critical Factors Influencing the In Vivo Performance of Long-acting Lipophilic Solutions—Impact on In Vitro Release Method Design

  2009cites this paper
• Effects of recombinant human LH and hCG on serum and urine LH and androgens in men

  2009cites this paper
• Role of in vitro release models in formulation development and quality control of parenteral depots

  2009cites this paper
• Anabolic-androgenic steroid effects on early morbid symptoms after open prostatectomy: A pilot study

  2008cites this paper
• Anabolic androgenic steroids and central monoaminergic systems : Supratherapeutic doses of nandrolone decanoate affect dopamine and serotonin

  2008cites this paper
• Prodrugs: design and clinical applications

  2008cites this paper
• Paraffinoma and ulcer of the external genitalia after self‐injection of nandrolone

  2008cites this paper
• Pharmacokinetic-pharmacodynamic modeling of the effect of fluvoxamine on p-chloroamphetamine-induced behavior.

  2007cites this paper
• Quantitative Bestimmung von 19-Norsteroiden nach peroraler und sublingualer Applikation von Norandrostendion und Norandrostendiol

  2007cites this paper
• Pharmacokinetics of boldenone and stanozolol and the results of quantification of anabolic and androgenic steroids in race horses and nonrace horses.

  2007cites this paper
• QUANTITATIVE DETERMINATION OF METABOLIC PRODUCTS OF 19-NORANDROSTENEDIOL IN HUMAN PLASMA USING GAS CHROMATOGRAPHY/MASS SPECTROMETRY

  2006cites this paper
• Long-acting testosterone undecanoate for parenteral testosterone therapy

  2006cites this paper
• Subcutaneous administration of testosterone. A pilot study report.

  2006cites this paper
• Significance of 19-norandrosterone in athletes’ urine samples

  2006cites this paper
• Pharmacokinetic evaluation of three different intramuscular doses of nandrolone decanoate: analysis of serum and urine samples in healthy men.

  2005cites this paper
• [Androgen replacement therapy in androgen deficiency in the ageing male].

  2004cites this paper
• Testosterone: Pharmacology of testosterone preparations

  2004cites this paper
• Update on nandrolone and norsteroids: how endogenous or xenobiotic are these substances?

  2004influential citation
• Ascertainment and Treatment of Delayed Puberty

  2003cites this paper
• Anabolic steroids in sport: biochemical, clinical and analytical perspectives

  2003cites this paper
• Age related changes of the PK-PD of intravenous anaesthetics.

  2003cites this paper
• Prinzipien der Therapie

  2003cites this paper
• Sustained delivery of human growth hormone from a novel gel system: SABER.

  2002cites this paper
• Body composition and anthropometry in bodybuilders: regional changes due to nandrolone decanoate administration.

  2001cites this paper
• Influence of implantation site and track geometry on the extrusion rate and pharmacology of testosterone implants

  2001cites this paper
• Urinary nandrolone metabolites of endogenous origin in man: a confirmation by output regulation under human chorionic gonadotropin stimulation.

  2001cites this paper
• Oestradiol enhances testosterone-induced suppression of human spermatogenesis.

  2000cites this paper
• Nandrolone et norstéroïdes: Substances endogènes ou xénobiotiques?

  2000cites this paper
• Evidence for the presence of endogenous 19-norandrosterone in human urine.

  1999cites this paper
• Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies.

  1999cites this paper
• Approche pharmaceutique du dopage à la nandrolone

  1998cites this paper
• Comparative pharmacokinetics of testosterone esters

  1998cites this paper
• EFFECT OF ANDROGEN ADMINISTRATION DURING PUBERTY ON HEPATIC CYP 2 C 11 , CYP 3 A , AND CYP 2 A 1 EXPRESSION IN ADULT FEMALE RATS

  1998cites this paper
• Effect of androgen administration during puberty on hepatic CYP2C11, CYP3A, and CYP2A1 expression in adult female rats.

  1998cites this paper
• Expanding clinical applications of population pharmacodynamic modelling.

  1998cites this paper
• Acta Universitatis Upsaliensis Uppsala 2013

  year unknowncites this paper
• Acta Universitatis Upsaliensis Uppsala 2008

  year unknowncites this paper
• Pharmacological characterization of potent and selective Free Fatty Acid Receptor 1 ( FFA 1 / GPR 40 ) agonists for the treatment of type 2 diabetes View project

  year unknowncites this paper